Kymera Therapeutics, Inc. (KYMR)
82.21
-2.29
(-2.71%)
USD |
NASDAQ |
May 15, 16:00
82.23
+0.02
(+0.02%)
After-Hours: 20:00
Kymera Therapeutics Market Cap : 6.762B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 160.88B |
| Revolution Medicines, Inc. | 30.97B |
| Catalyst Pharmaceuticals, Inc. | 3.816B |
| Regeneron Pharmaceuticals, Inc. | 73.20B |
| AbbVie, Inc. | 371.72B |
Market Cap Related Metrics
| PS Ratio | 141.82 |
| PEG Ratio | -1.513 |
| Price to Book Value | 4.392 |
| Price | 82.21 |
| Earnings Yield | -4.34% |
| PEGY Ratio | -1.513 |